Clinical Evidence of Nasal High-Flow Therapy in Chronic Obstructive Pulmonary Disease Patients

Judith Elshof*, Marieke L Duiverman

*Bijbehorende auteur voor dit werk

    Onderzoeksoutput: Review articlepeer review

    6 Citaten (Scopus)
    39 Downloads (Pure)


    Nasal high-flow therapy (NHFT) is an upcoming treatment for chronic obstructive pulmonary disease (COPD) patients. It supplies heated, humidified, and, desirably, oxygen-enriched air through a nasal cannula at flow rates up to 60 L/min. Several studies examined the effect of NHFT in COPD patients, but a clear overview is lacking. The present review aimed to give an overview of the clinical evidence of NHFT in 3 aspects of COPD care: long-term use in stable COPD patients, use for treatment of COPD exacerbations, and use during exercise therapy in COPD. For each topic, a specific literature search was performed up to December 9, 2019. Studies show promising results, with most evidence for its long-term use in hypoxemic COPD patients that frequently exacerbate, and very limited evidence for its use during COPD exacerbations or as a worthwhile adjunct to exercise training. More evidence is therefore needed to know how to incorporate NHFT in standard clinical practice.

    Originele taal-2English
    Pagina's (van-tot)140-153
    Aantal pagina's14
    Nummer van het tijdschrift2
    Vroegere onlinedatum28-jan-2020
    StatusPublished - 2020

    Citeer dit